Treatments for COVID-19: emerging drugs against the coronavirus.
Acta bio-medica : Atenei Parmensis, 2020 The Coronavirus disease 19 (COVID-19) outbreak has been recognized as a global threat to public health. It is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and no effective therapies currently exist against this novel viral agent.
Potì, Francesco +4 more
openaire +7 more sources
Drug repositioning is an alternative for the treatment of coronavirus COVID-19
International Journal of Antimicrobial Agents, 2020 Given the extreme importance of the current pandemic caused by COVID-19, and as scientists agree there is no identified pharmacological treatment, where possible, therapeutic alternatives are raised through drug repositioning. This paper presents a selection of studies involving drugs from different pharmaceutical classes with activity against SARS-CoV-
Serafin, Marissa B. +5 more
openaire +3 more sources
Guidance on Short‐Term Management of Atrial Fibrillation in Coronavirus Disease 2019
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2020 Atrial fibrillation is a common clinical manifestation in hospitalized patients with coronavirus disease 2019 (COVID‐19). Medications used to treat atrial fibrillation, such as antiarrhythmic drugs and anticoagulants, may have significant drug ...
Pattara Rattanawong +6 more
doaj +1 more source
Repurposing anticancer drugs for the management of COVID-19 [PDF]
, 2020 Since its outbreak in the last December, coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 has rapidly spread worldwide at a pandemic proportion and thus is regarded as a global public health emergency.
Afqir, Said +8 more
core +1 more source
Management of pregnancy-related hypertensive disorders in patients infected with SARS CoV-2: pharmacological and clinical issues [PDF]
, 2020 Aims: Coronavirus-19 infection (COVID-19) continues to spread throughout the world. It is known that among patients with hypertension, diabetes, chronic respiratory disease, or cardiovascular (CV) diseases, COVID-19 is associated with greater morbidity
Arrigo F. G. Cicero +5 more
core +1 more source
Potential therapeutic drug candidates against SARS-CoV-2 (COVID‐19) through molecular docking: A review [PDF]
Health Science Monitor, 2022 The severe acute respiratory syndrome coronavirus 2 (known as COVID-19), initially appeared in the Wuhan city of China in December 2019, has become a current medical issue around the world.
Aynaz Nourani +2 more
doaj
A literature review of pandemic novel coronavirus disease 2019 and potential drugs treatment [PDF]
, 2021 Background: Coronaviruses (CoVs) belong to a family that comes under the order “Nidovirales.” Nidovirales order includes the viruses that use a nested set of mRNAs for their replication.
Devki, Shishir Mohan +1 more
core +1 more source
Role of monoclonal antibody drugs in the treatment of COVID-19
World Journal of Clinical Cases, 2020 Currently clinicians all around the world are experiencing a pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The clinical presentation of this pathology includes fever, dry cough, fatigue and acute respiratory distress syndrome that can lead to death infected patients.
Ucciferri C., Vecchiet J., Falasca K.
openaire +4 more sources
A Study On Potential Drug Target For SARS-CoV-2-And Combinatorial Therapeutic Approach To Combat COVID-19 [PDF]
The COVID-19 pandemic caused by (SARS-CoV-2) a threat, leading to numerous deaths and socioeconomic disruptions. Spurred intense research efforts effective treatment. Our study provides a brief overview COVID-19.
Debojyati Datta, Semanti Ghosh
core +2 more sources
Determination of Potential Drug Candidate Molecules of the Hypericum perforatum for COVID-19 Treatment [PDF]
, 2021 The novel human coronavirus was firstly emerged in December 2019 in Wuhan, China, and has spread rapidly around the world. There is no known specific effective treatment of COVID-19.
Ercan, Fahriye +2 more
core +1 more source